LMAM
JAZZ icon

Legg Mason Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Legg Mason Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,500
Closed -$1.87M – 127
2014
Q1 		$1.87M Sell
13,500
-1,600
-11% -$241K 1.1% 22
2013
Q4 		$1.91M Sell
15,100
-2,900
-16% -$300K 1.1% 24
2013
Q3 		$1.66M Buy
+18,000
New +$1.45M 0.9% 44

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Legg Mason Asset Management's JAZZ Position: Q2 2014 in Review

Legg Mason Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2014, closing a stake of 13,500 shares — an estimated $1.87M sold.

Legg Mason Asset Management first reported a position in JAZZ in Q3 2013 and held it in 3 quarters. The position peaked at $1.91M in Q4 2013. 305 funds tracked by Wall St. Rank hold JAZZ as of Q2 2014.

  • Legg Mason Asset Management reported no remaining Jazz Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Legg Mason Asset Management sold 13,500 Jazz Pharmaceuticals shares in Q2 2014, an estimated $1.87M.
  • Legg Mason Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 3 quarters.
  • Legg Mason Asset Management's Jazz Pharmaceuticals position peaked at $1.91M in Q4 2013.
  • 305 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2014.

Based on Legg Mason Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.